Labcorp buys into Sera, to distribute preterm birth test

Sera Prognostics Inc. (Salt Lake City, Utah) raised $40 million in a series C round led by Laboratory Corp. of America Holdings (NYSE:LH). Also participating were existing investors Domain Associates, InterWest Partners, Catalyst Health Ventures and the Bill & Melinda Gates Foundation.

Sera also said LabCorp will be the exclusive distributor of the company’s PreTRM test in the U.S. Sera began a limited release of the test last year, and intends to make the product available throughout the U.S. this year...